Hand R, Salman S, Newall N, Vine J, Page-Sharp M, Bowen A
J Antimicrob Chemother. 2019; 74(7):1984-1991.
PMID: 30989171
PMC: 6587412.
DOI: 10.1093/jac/dkz076.
Komatsu T, Inomata T, Watanabe I, Kobayashi M, Kokubun H, Ako J
J Pharm Health Care Sci. 2016; 2:9.
PMID: 27051524
PMC: 4820900.
DOI: 10.1186/s40780-016-0043-x.
Huttenrauch R, SPEISER P
Pharm Res. 2013; 2(3):97-107.
PMID: 24272686
DOI: 10.1023/A:1016355114960.
Pedersen A, Jakobsen P, Kampmann J, Hansen J
Clin Pharmacokinet. 1982; 7(1):42-56.
PMID: 7042172
DOI: 10.2165/00003088-198207010-00003.
Brater D
Drugs. 1980; 19(1):31-48.
PMID: 6988197
DOI: 10.2165/00003495-198019010-00003.
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
Frimodt-Moller N, Maigaard S, Toothaker R, Bundtzen R, Brodey M, Craig W
Antimicrob Agents Chemother. 1980; 17(4):599-607.
PMID: 6446877
PMC: 283838.
DOI: 10.1128/AAC.17.4.599.
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.
Verbeeck R, Blackburn J, Loewen G
Clin Pharmacokinet. 1983; 8(4):297-331.
PMID: 6352138
DOI: 10.2165/00003088-198308040-00003.
Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone.
Strong H, Angus R, Oates J, Sembi J, Howarth P, Renwick A
Clin Pharmacokinet. 1986; 11(5):402-10.
PMID: 3780113
DOI: 10.2165/00003088-198611050-00005.
Saturable pharmacokinetics in the renal excretion of drugs.
van Ginneken C, Russel F
Clin Pharmacokinet. 1989; 16(1):38-54.
PMID: 2650954
DOI: 10.2165/00003088-198916010-00003.
Effects of diclofenac on ceftriaxone pharmacokinetics in humans.
Bresler L, Lokiec F, Dopff C, Boissel P, DUREUX J
Antimicrob Agents Chemother. 1992; 36(10):2331-3.
PMID: 1444314
PMC: 245498.
DOI: 10.1128/AAC.36.10.2331.
Editorials: Rational drug therapy in patients with renal disease.
Brater D, Morrelli H
West J Med. 1975; 123(5):393-4.
PMID: 1210332
PMC: 1129928.
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.
Pagliaro L, Benet L
J Pharmacokinet Biopharm. 1975; 3(5):333-83.
PMID: 1107513
DOI: 10.1007/BF01082306.
Platelets, thrombosis and drugs.
Mustard J, Packham M
Drugs. 1975; 9(1):19-76.
PMID: 1092540
DOI: 10.2165/00003495-197509010-00003.
Drug kinetics and artificial kidneys.
Gibson T, NELSON H
Clin Pharmacokinet. 1977; 2(6):403-26.
PMID: 22417
DOI: 10.2165/00003088-197702060-00002.
